Truist Securities Reiterates Hold Rating on Teladoc (TDOC)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/25/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
Teladoc (TDOC) +2% on addition of GLP-1 self-pay option with Lilly
March 6, 2025 8:52 AM ESTTeladoc (TDOC) +2% on addition of GLP-1 self-pay option with Lilly
... MoreTeladoc (TDOC) announces inducement awards to 21 new employees
March 5, 2025 6:04 PM ESTTeladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced that it issued inducement awards to 21 new employees.
Effective February 28, 2025 and March 1, 2025, in connection with the acquisition of Catapult Health on February 28, 2025, 19 employees of Catapult Health were granted awards of restricted stock units covering an aggregate of 365,282 shares of Teladoc Healths common stock, par value $0.001 per share (Common Stock), and... More
